Mara Joseph Anthony Jr has amended a filing regarding the sale of shares in Vericel Corp, a company involved in biological products. This amendment is significant as it reflects ongoing insider transactions that can impact investor perceptions and market dynamics.

Background

Vericel Corp, which operates under the Central Index Key (CIK) 0000887359, is classified under the SIC code for Biological Products (No Diagnostic Substances) [2836]. The company is incorporated in Michigan and has its business address at 25 Blue Sky Drive, Burlington, MA. Its fiscal year ends on December 31. Recent filings include a Form 144/A submitted on November 6, 2026, and a Form 144 filed on the same day, indicating active share transactions.

What the Filing Says

The amended filing indicates that Mara Joseph Anthony Jr exercised stock options to acquire 28,641 shares of Vericel Corp on November 6, 2026. The filing also notes that the shares sold were part of a previous transaction reported on November 5, 2026, where 21,359 shares were sold for gross proceeds of $1,144,079.15. The amendment specifies that this Form 144/A supersedes the earlier Form 144 filed on the same date, updating the Plan Adoption Date.

Impact

This filing may affect investors and analysts monitoring insider trading activity at Vericel Corp. The details of stock options and share sales can provide insights into the confidence levels of company executives regarding the firm's future. Such transactions are closely watched as they can signal management's outlook on the company’s performance.

What's Next

The filing does not say what happens next.